Axel Nierhaus to Critical Illness
This is a "connection" page, showing publications Axel Nierhaus has written about Critical Illness.
Connection Strength
0.242
-
MR-proAdrenomedullin as a predictor of renal replacement therapy in a cohort of critically ill patients with COVID-19. Biomarkers. 2021 Jul; 26(5):417-424.
Score: 0.165
-
Mechanical ventilation and mortality among 223 critically ill patients with coronavirus disease 2019: A multicentric study in Germany. Aust Crit Care. 2021 Mar; 34(2):167-175.
Score: 0.040
-
High estradiol and low testosterone levels are associated with critical illness in male but not in female COVID-19 patients: a retrospective cohort study. Emerg Microbes Infect. 2021 Dec; 10(1):1807-1818.
Score: 0.011
-
Targeting Endothelial Dysfunction in Eight Extreme-Critically Ill Patients with COVID-19 Using the Anti-Adrenomedullin Antibody Adrecizumab (HAM8101). Biomolecules. 2020 08 11; 10(8).
Score: 0.010
-
Pharmacokinetics of meropenem in septic patients on sustained low-efficiency dialysis: a population pharmacokinetic study. Crit Care. 2018 01 30; 22(1):25.
Score: 0.008
-
Population pharmacokinetics and dosing simulations of ceftazidime in critically ill patients receiving sustained low-efficiency dialysis. J Antimicrob Chemother. 2017 05 01; 72(5):1433-1440.
Score: 0.008